Beth Hollister

ScholarGPS® ID: 92218425623141

Affiliation History

Field
Medicine
Discipline
Oncology
Top Specialties
Cancer
Metrics Summary
Publication Count
8
Predicted Citations
355
Predicted h-index
8
Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

You must register and claim your profile to add or remove publications from it.
... publications
FILTER BY:
Year
Type
Specialty
Affiliations
Access
Co-Authors
Delete
GEM 231, a second-generation antisense agent complementary to protein kinase A RIalpha subunit, potentiates antitumor activity of irinotecan in human colon, pancreas, prostate and lung cancer xenografts. (journal article)
International journal of oncology, volume 21, issue 1 (2002).